The Treatment Optimisation Toolkit (TOT) is an interactive digital programme in which healthcare professionals can explore appropriate treatment pathways for patients with ADHD, aged 6-17 years old.

The Management of Adult ADHD Pack (MAP) is an interactive digital programme that aims to help healthcare professionals further understand treatment pathways for adult patients (≥ 18 years) with ADHD.

In this video Prof. Susan Young, explores ADHD in teenage girls—covering diagnostic challenges, symptom masking, and unique risks. Featuring case study discussions from Dr. Helen Tindle.

Dr. Sara Binder and Dr. Joe Johnson discuss the considerations when managing female ADHD patients to ensure they are treated optimally.

Dr. Sara Binder introduces one of her patient's journeys through marriage, motherhood and her career with ADHD.

Dr. Christopher Abbott leads a practical session on how to support adolescents with ADHD to maintain effective care into adulthood.  He explores why transition so often fails despite symptom persistence, highlights the real-world prescribing “drop-off” around ages 16–18, and shares actionable tools to improve continuity of care.

Follow Professor Peter Hill as he explores how ADHD symptoms can manifest from adolescence to adulthood (16–26). The complexities that come with this transition are detailed as well as practical advice to support a more effective transition into adulthood.

In this video Prof. Susan Young, explores ADHD in teenage girls—covering diagnostic challenges, symptom masking, and unique risks. Featuring case study discussions from Dr. Helen Tindle.

Kobus van Rensburg discusses ADHD and autism in youth, covering prevalence, diagnostic overlap, assessment strategies, comorbidity, differential traits, and emphasizes personalized, person-centred support approaches.

Prof. Buitelaar discusses clinical diagnosis, overlap and implications for treatment of ADHD and Autism Spectrum Disorders.

Expert talk by Prof. David Nutt examining the intersection of addiction and ADHD, discussing neurobiological mechanisms, comorbidity, and treatment approaches, with clinical anecdotes highlighting diagnostic complexities, the role of dopamine, and the impact of stimulant therapy on substance use and behavioural addictions.

Prof. Gabriele Fischer presents on the link between ADHD and substance use disorder, gambling, and food addiction.

Dr Peter Mason discusses the management of ADHD in people with substance use disorder, and summarises the conclusions of an expert consensus statement on this topic.

In this talk, listen to Dr Mischa Mockett and Dr Joe Johnson explore the complex overlap between ADHD and intellectual disabilities, offering a clinically grounded and highly practical guide for recognising, diagnosing, and managing ADHD in individuals with varying levels of cognitive impairment.

Dr. Caroline Bleakley discusses ADHD in teens, focusing on treatment optimization, physical health links, emotional dysregulation, comorbidities, benchmarking tools, medication strategies, and the importance of individualized, holistic care.

Dr. Duncan Manders and Dr. Sonia Gleeson discuss trauma’s impact on ADHD diagnosis and management, exploring neurobiological models, FASD, and advocating for trauma-informed, holistic assessment strategies.

Prof. David Coghill provides an overview on ADHD drugs action.

Dr. Giaroli explores the psychopharmacology of medications licensed to treat children and young people with ADHD.

Dr. Christopher Abbott leads a practical session on how to support adolescents with ADHD to maintain effective care into adulthood.  He explores why transition so often fails despite symptom persistence, highlights the real-world prescribing “drop-off” around ages 16–18, and shares actionable tools to improve continuity of care.

Follow Professor Peter Hill as he explores how ADHD symptoms can manifest from adolescence to adulthood (16–26). The complexities that come with this transition are detailed as well as practical advice to support a more effective transition into adulthood.

A real-world ADHD journey: Watch how transition, treatment choices, and support can help shape outcomes for young adults.

Dr. Joe Johnson provides an evidence-based overview of pharmacological treatment options for adult ADHD, focusing on why stimulants are typically first choice, what major analyses and guidelines suggest, and how to translate this evidence into practical treatment decisions in ADHD care.

Dr. Kenny Handelman, a psychiatrist specialising in child, adolescent, and adult mental health, as well as an assistant clinical professor at a Canadian university, explores goal-oriented treatment approaches for adults diagnosed with ADHD.

Prof. Raja Mukherjee provides expert insight into the Cortese et al. meta-analysis, evaluating ADHD treatment efficacy and tolerability, and discussing clinical implications for personalised care and medication strategies.

This patient leaflet offers practical tips for adults with ADHD working from home, covering routines, task management, sleep hygiene, digital organisation, and strategies to improve focus, productivity, and wellbeing.

The patient leaflet provides practical tips for families with children who have ADHD, focusing on routines, visual aids, behaviour management, sleep strategies, sibling support, and techniques to prevent emotional meltdowns.